Cyclerion Therapeutics, Inc. Gains 73.18%

Wed, Jul 10, 2024 at 07:12 PM
Cyclerion Therapeutics, Inc. Gains 73.18%

Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) shot up at $3.81, representing a gain of 73.2%. On Wed, Jul 10, 2024, CYCN:NASDAQ hit a New 2-Week High of $3.81. From Wed, Jun 26, 2024, the stock recorded 55.56% Up Days and 70.00% Green Days

About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.